Granules India Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Granules India de 24.6% y 11.8% por año respectivamente. Se prevé que el BPA crezca en un 24.3% al año. Se espera que la rentabilidad financiera sea de 16.5% en 3 años.

Información clave

24.6%

Tasa de crecimiento de los beneficios

24.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	17.7%
Tasa de crecimiento de los ingresos	11.8%
Rentabilidad financiera futura	16.5%
Cobertura de analistas	Good
Última actualización	08 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Granules India Limited Just Missed Revenue By 6.4%: Here's What Analysts Think Will Happen Next

Jan 26

Recent updates

Investors Holding Back On Granules India Limited (NSE:GRANULES)

Apr 08

Granules India Limited Just Missed Revenue By 6.4%: Here's What Analysts Think Will Happen Next

Jan 26

These 4 Measures Indicate That Granules India (NSE:GRANULES) Is Using Debt Reasonably Well

Dec 21

Here's Why I Think Granules India (NSE:GRANULES) Is An Interesting Stock

Aug 18

Granules India (NSE:GRANULES) Will Pay A Dividend Of ₹0.25

Aug 03

Is Granules India (NSE:GRANULES) Using Too Much Debt?

Jun 11

Why Granules India Limited (NSE:GRANULES) Is A Dividend Rockstar

May 02

Does This Valuation Of Granules India Limited (NSE:GRANULES) Imply Investors Are Overpaying?

Mar 26

What Kind Of Investors Own Most Of Granules India Limited (NSE:GRANULES)?

Mar 14

These 4 Measures Indicate That Granules India (NSE:GRANULES) Is Using Debt Reasonably Well

Mar 01

Granules India Limited (NSE:GRANULES) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Feb 16

Why You Might Be Interested In Granules India Limited (NSE:GRANULES) For Its Upcoming Dividend

Feb 03

Analysts Have Made A Financial Statement On Granules India Limited's (NSE:GRANULES) Third-Quarter Report

Jan 30

Here's Why We Think Granules India (NSE:GRANULES) Is Well Worth Watching

Jan 20

Have Insiders Sold Granules India Limited (NSE:GRANULES) Shares Recently?

Jan 07

Announcing: Granules India (NSE:GRANULES) Stock Increased An Energizing 198% In The Last Year

Dec 28

Granules India Limited's (NSE:GRANULES) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Dec 15

Previsiones de crecimiento de beneficios e ingresos

NSEI:GRANULES - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	62,732	7,716	N/A	N/A	1
3/31/2026	59,493	7,327	5,885	N/A	6
3/31/2025	52,564	6,041	1,088	N/A	6
3/31/2024	45,623	4,184	979	N/A	6
12/31/2023	45,261	3,953	N/A	N/A	N/A
9/30/2023	45,166	3,939	-346	3,769	N/A
6/30/2023	44,779	4,369	N/A	N/A	N/A
3/31/2023	45,119	5,166	3,281	7,387	N/A
12/31/2022	43,464	5,080	N/A	N/A	N/A
9/30/2022	41,970	4,845	1,545	4,970	N/A
6/30/2022	39,346	4,201	N/A	N/A	N/A
3/31/2022	37,649	4,128	-657	3,321	N/A
12/31/2021	35,343	4,293	N/A	N/A	N/A
9/30/2021	33,820	4,753	735	4,714	N/A
6/30/2021	33,518	5,582	N/A	N/A	N/A
3/31/2021	32,375	5,495	1,611	4,325	N/A
12/31/2020	30,381	5,142	N/A	N/A	N/A
9/30/2020	28,976	4,314	2,723	4,459	N/A
6/30/2020	27,390	3,636	N/A	N/A	N/A
3/31/2020	25,986	3,354	2,917	4,762	N/A
12/31/2019	26,121	3,071	N/A	N/A	N/A
9/30/2019	25,399	3,034	1,551	3,714	N/A
6/30/2019	24,212	2,679	N/A	N/A	N/A
3/31/2019	22,792	2,364	-172	2,622	N/A
12/31/2018	21,697	1,928	N/A	N/A	N/A
9/30/2018	19,487	1,675	N/A	N/A	N/A
6/30/2018	17,603	1,476	N/A	N/A	N/A
3/31/2018	16,846	1,326	-4,471	-7	N/A
12/31/2017	15,361	1,578	N/A	N/A	N/A
9/30/2017	14,785	1,619	N/A	N/A	N/A
6/30/2017	14,456	1,624	N/A	N/A	N/A
3/31/2017	14,106	1,645	N/A	1,882	N/A
12/31/2016	14,971	1,473	N/A	N/A	N/A
9/30/2016	14,626	1,374	N/A	N/A	N/A
6/30/2016	14,524	1,289	N/A	N/A	N/A
3/31/2016	13,572	1,230	N/A	1,514	N/A
12/31/2015	14,147	1,077	N/A	N/A	N/A
9/30/2015	13,895	1,041	N/A	N/A	N/A
6/30/2015	13,307	952	N/A	N/A	N/A
3/31/2015	12,937	909	N/A	1,503	N/A
12/31/2014	12,573	921	N/A	N/A	N/A
9/30/2014	12,217	904	N/A	N/A	N/A
6/30/2014	11,786	834	N/A	N/A	N/A
3/31/2014	10,973	752	N/A	1,079	N/A
12/31/2013	9,837	640	N/A	N/A	N/A
9/30/2013	8,948	480	N/A	N/A	N/A
6/30/2013	8,034	410	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (24.6% al año) de GRANULES es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (24.6% al año) de GRANULES crezcan más rápidamente que el mercado Indian (18% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de GRANULES crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (11.8% al año) de GRANULES crezcan más rápidamente que los del mercado Indian (10.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 11.8% al año) de GRANULES crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de GRANULES sea baja dentro de 3 años (16.5%).

Granules India Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Granules India Limited Just Missed Revenue By 6.4%: Here's What Analysts Think Will Happen Next

Price target increased by 8.1% to ₹375

Price target increased to ₹338

Price target decreased to ₹319

Price target decreased to ₹330

Price target decreased to ₹388

Recent updates

Granules India Limited to Report Q4, 2024 Results on May 15, 2024

High number of new directors

Investors Holding Back On Granules India Limited (NSE:GRANULES)

Granules India Limited Appoints Atul Dhavle as Chief Human Resources Officer

Granules India Limited Announces That J. Shravan Reddy Shall Cease to Be Senior Vice President & Head- API Manufacturing

Granules India Limited Just Missed Revenue By 6.4%: Here's What Analysts Think Will Happen Next

Third quarter 2024 earnings released: EPS: ₹5.18 (vs ₹5.11 in 3Q 2023)

Granules India Limited to Report Q3, 2024 Results on Jan 23, 2024

Many Still Looking Away From Granules India Limited (NSE:GRANULES)

Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets

Granules India (NSE:GRANULES) Has A Pretty Healthy Balance Sheet

Price target increased by 8.1% to ₹375

Second quarter 2024 earnings released: EPS: ₹4.22 (vs ₹5.85 in 2Q 2023)

Granules India Limited to Report Q2, 2024 Results on Nov 09, 2023

A Look At The Fair Value Of Granules India Limited (NSE:GRANULES)

Granules India Limited Receives ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules

Granules India Limited Approves Final Dividend for the Fy 2022-23

Granules India Limited Receives US FDA Approval for the ANDA Files for Metoprolol Succinate ER Tablets Registered Office

Granules India Limited to Report Q1, 2024 Results on Aug 09, 2023

Upcoming dividend of ₹1.50 per share at 0.5% yield

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Granules India Limited Announces Approval for the Store Brand OTC Equivalent of Advil®? Dual Action Tablets Registered Office

Granules India Limited Receives ANDA Approval for Venlafaxine ER Capsules

Does Granules India (NSE:GRANULES) Have A Healthy Balance Sheet?

Granules India Limited, Annual General Meeting, Aug 10, 2023

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Should You Be Adding Granules India (NSE:GRANULES) To Your Watchlist Today?

Third quarter 2023 earnings: EPS misses analyst expectations

Granules India (NSE:GRANULES) Has A Pretty Healthy Balance Sheet

Granules India Limited to Report Q3, 2023 Results on Jan 24, 2023

Granules India Limited Announces Resignation of Sandip Neogi as Chief Financial Officer (Cfo)

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Granules India Limited to Report Q2, 2023 Results on Oct 20, 2022

Does Granules India (NSE:GRANULES) Have A Healthy Balance Sheet?

Granules India Limited Receives Approval for Abbreviated New Drug Application from US Food & Drug Administration

Estimating The Intrinsic Value Of Granules India Limited (NSE:GRANULES)

Price target increased to ₹338

Granules India Limited (BSE:532482) announces an Equity Buyback for 6,250,000 shares, representing 2.52% for INR 2,500 million.

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Granules India Limited to Report Q1, 2023 Results on Aug 09, 2022

Granules India Limited Approves Final Dividend for the Financial Year 2021-22

Granules India (NSE:GRANULES) Is Due To Pay A Dividend Of ₹0.75

Upcoming dividend of ₹0.75 per share

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Is Granules India (NSE:GRANULES) A Risky Investment?

Now 21% undervalued after recent price drop

Price target decreased to ₹319

Granules India (NSE:GRANULES) Will Pay A Dividend Of ₹0.75

Granules India Limited, Annual General Meeting, Jul 27, 2022

Price target decreased to ₹330

Granules India Recommends Final Dividend for the Financial Year 2021-22

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estimating The Fair Value Of Granules India Limited (NSE:GRANULES)

Granules India (NSE:GRANULES) Is Due To Pay A Dividend Of ₹0.25

Granules India Limited Declares Third Interim Dividend for the Financial Year 2021-22

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Calculating The Intrinsic Value Of Granules India Limited (NSE:GRANULES)

Now 21% undervalued after recent price drop

Here's Why We Think Granules India (NSE:GRANULES) Is Well Worth Watching

These 4 Measures Indicate That Granules India (NSE:GRANULES) Is Using Debt Reasonably Well

Insufficient new directors

Second quarter 2022 earnings released: EPS ₹3.26 (vs ₹6.60 in 2Q 2021)

Upcoming dividend of ₹0.25 per share

Price target decreased to ₹388

Here's Why I Think Granules India (NSE:GRANULES) Is An Interesting Stock

Insider recently sold ₹1.2m worth of stock

Granules India (NSE:GRANULES) Will Pay A Dividend Of ₹0.25

Upcoming dividend of ₹0.25 per share